<HTML>
<HEAD>
<TITLE>PSYCHIATRIC SOLUTIONS, INC.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 4, 2006
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">REGISTRATION NO. 333-________
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>WASHINGTON, D.C. 20549</B></DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>Form&nbsp;S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT UNDER THE<BR>
SECURITIES ACT OF 1933</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>PSYCHIATRIC SOLUTIONS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact Name of Registrant as Specified in its Charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>23-2491707</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction of
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">Incorporation or Organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>840 Crescent Centre Drive, Suite&nbsp;460</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>Franklin, Tennessee</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>37067</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan</B><BR>
(Full title of the plan)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Christopher L. Howard, Esq.<BR>
Executive Vice President, General Counsel and Secretary<BR>
Psychiatric Solutions, Inc.<BR>
840 Crescent Centre Drive, Suite&nbsp;460<BR>
Franklin, Tennessee 37067<BR>
(Name and Address of Agent for Service)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">(615)&nbsp;312-5700<BR>
(Telephone number, including area code, of agent for service)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Copies of all communications to:<BR>
James H. Nixon III, Esq.<BR>
Waller Lansden Dortch &#038; Davis, LLP<BR>
511 Union Street, Suite&nbsp;2700<BR>
Nashville, Tennessee 37219-1760<BR>
(615)&nbsp;244-6380
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CALCULATION OF REGISTRATION FEE</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="41%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="21" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount Of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Title Of Each Class Of</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount To Be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum Offering</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum Aggregate</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registration</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Securities To Be Registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Price Per Unit</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Offering Price</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Fee (3)</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD valign="top" style="border-top: 2px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">Common Stock of
Psychiatric
Solutions, Inc.,
par value $0.01 per
share
</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 2px solid #000000">1,250,000 (1)
</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="top" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" valign="top" style="border-top: 2px solid #000000">30.98</TD>
    <TD nowrap valign="top" style="border-top: 2px solid #000000">(2)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="top" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" valign="top" style="border-top: 2px solid #000000">38,725,000</TD>
    <TD nowrap valign="top" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="top" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" valign="top" style="border-top: 2px solid #000000">4,144</TD>
    <TD nowrap valign="top" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="21" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Represents shares of common stock, par value $.01 per share (&#147;Common Stock&#148;), of
Psychiatric Solutions, Inc. (&#147;Psychiatric Solutions&#148;) reserved for issuance pursuant to future
grants of stock options under the Amended and Restated Psychiatric Solutions, Inc. Equity
Incentive Plan, as amended (the &#147;Equity Incentive Plan&#148;).</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated pursuant to Rule 457(c) solely for purposes of calculating the amount of the
registration fee, based upon the average of the high and low prices of Common Stock of
Psychiatric Solutions, as reported on the Nasdaq Global Select Market on July&nbsp;31, 2006.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Equity Incentive Plan authorizes the issuance of a maximum of 11,116,666 shares of Common
Stock, of which 4,000,000 shares have been registered pursuant to a previously filed
registration statement on Form&nbsp;S-8 (No.&nbsp;333-128047), 957,132 shares have been registered pursuant to a previously filed registration
statement on Form&nbsp;S-8 (No.&nbsp;333-38419), 666,666 shares have been registered on a previously
filed registration statement on Form&nbsp;S-8 (No.&nbsp;333-94983), 3,246,112 shares have been
registered pursuant to a previously filed registration statement on Form&nbsp;S-8 (No.&nbsp;333-118529)
and 333,332 shares have been registered on a previously filed registration statement on Form
S-8 (No.&nbsp;33-72664). In connection with the amendment and restatement of the Equity Incentive
Plan on May&nbsp;6, 2003, the Psychiatric Solutions, Inc. 1997 Incentive and Non-Qualified Stock
Option Plan for Key Personnel (the &#147;Psychiatric Plan&#148;) was merged into the Equity Incentive
Plan. The Psychiatric Plan authorized the issuance of a maximum of 331,712 shares of Common
Stock, all of which shares have been registered pursuant to a previously filed registration
statement on Form&nbsp;S-8 (No.&nbsp;333-100635). An additional 1,250,000 shares of Common Stock are
being registered herewith and, in accordance with General Instruction E of Form S-8, the fee
is being paid only with respect to these shares. All share numbers, purchase prices per share
and exercise prices set forth in this registration statement have been adjusted to reflect (a)
the exchange ratio in the merger between Psychiatric Solutions and PMR Corporation on August
5, 2002, (b)&nbsp;a 1-for-3 reverse stock split effected on August&nbsp;5, 2002 and (c)&nbsp;a 2-for-1 stock
split effected in the form of a 100% stock dividend on January&nbsp;9, 2006.</TD>
</TR>


</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Reoffer Prospectus</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>1,250,000 Shares</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Psychiatric Solutions, Inc.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Common Stock</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has been prepared for use by certain affiliates and employees (the &#147;Selling
Stockholders&#148;) of Psychiatric Solutions, Inc. (&#147;Psychiatric Solutions&#148;) who may offer and sell up
to an aggregate of 1,250,000 shares of common stock, par value $.01 per share (&#147;Common Stock&#148;),
that the Selling Stockholders acquire pursuant to the Amended and Restated Psychiatric Solutions,
Inc. Equity Incentive Plan, as amended (the &#147;Incentive Plan&#148;), or upon the exercise, subsequent to
the date of this reoffer prospectus, of stock options granted pursuant to the Incentive Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus may only be used in conjunction with a supplement, if required under the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), that contains the names of the Selling
Stockholders and the amount of shares of Common Stock to be reoffered by them.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any of the proceeds from the sale of the shares by the Selling
Stockholders. We will bear all expenses (other than underwriting discounts and selling
commissions, fees and expenses of counsel and other advisors to the Selling Stockholders, transfer
taxes and related charges) in connection with the registration of the shares being offered by the
Selling Stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Common Stock is listed on the Nasdaq Global Select Market under the symbol &#147;PSYS.&#148; We are
incorporated under the laws of the State of Delaware. Our principal executive offices are located
at 840 Crescent Centre Drive, Suite&nbsp;460, Franklin, Tennessee 37067 and our telephone number is
(615)&nbsp;312-5700.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Investing in our Common Stock involves certain risks. Please carefully consider the &#147;Risk
Factors&#148; in our Annual Report on </B><B>Form 10-K</B><B> filed on March&nbsp;2, 2006, and incorporated by reference
into this prospectus.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission
has approved or disapproved of these securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">The date of this prospectus is August&nbsp;4, 2006.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><u><B>Heading</u></B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B><u>Page</u></B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#101">Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#102">Selling Stockholders</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#103">Plan of Distribution</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#104">Available Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#105">Incorporation of Certain Information By Reference</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#106">Legal Matters</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#107">Experts</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left">
<!-- /TOC -->
</DIV>
<DIV align="left">
<A name="101"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>USE OF PROCEEDS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any proceeds from the sale of shares of Common Stock by the Selling
Stockholders.
</DIV>
<DIV align="left">
<A name="102"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SELLING STOCKHOLDERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares of Common Stock issued pursuant to the Incentive Plan or upon the exercise,
subsequent to the date of this reoffer prospectus, of stock options granted pursuant to the
Incentive Plan have been registered under the Securities Act by a registration statement on Form
S-8. This prospectus may be used in connection with any resales of Common Stock acquired pursuant
to the Incentive Plan after the date of the registration statement on Form S-8 by persons who may
be considered our &#147;affiliates&#148; within the meaning of the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the date of this prospectus, we do not know the names of persons who intend to resell
shares of Common Stock acquired pursuant to the Incentive Plan. The Selling Stockholders will be
either employees, consultants or advisors of Psychiatric Solutions or its subsidiaries who have
been or may be granted options to purchase Common Stock or restricted shares of Common Stock under
the Incentive Plan. We will supplement this prospectus with the names of the Selling Stockholders
and the amount of shares of Common Stock to be reoffered by them as that information becomes known
and is required by the Securities Act.
</DIV>
<DIV align="left">
<A name="103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be offered by the Selling Stockholders from time to time in transactions
through the Nasdaq Global Select Market, in negotiated transactions, through the writing of options on
the shares or a combination of these methods of sale, at prices related to prevailing market prices
or at negotiated prices. The Selling Stockholders may effect these transactions by selling the
shares to or through broker-dealers and these broker-dealers may receive compensation in the form
of discounts, concessions or commissions from the Selling Stockholders and/or the purchaser of the
shares for which such broker-dealers may act as agent or to whom they sell as principal, or both.
This compensation as to a particular broker-dealer may be in excess of customary commissions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no assurance that any of the Selling Stockholders will sell any or all of the shares
of Common Stock offered under this prospectus.
</DIV>
<DIV align="left">
<A name="104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AVAILABLE INFORMATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the informational requirements of the Securities Exchange Act of 1934, as
amended (the &#147;Exchange Act&#148;), and, in accordance therewith, we file reports, proxy statements and
other information with the SEC under the Exchange Act. You may read and copy this information on
our website at www.psysolutions.com and at the following locations of the SEC:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Public Reference Room
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York Regional Office
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chicago Regional Office</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">450 Fifth Street, N.W.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Woolworth Center
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Citicorp Center, Suite&nbsp;1400</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Room&nbsp;1024
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">233 Broadway
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">500 West Madison Street</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Washington, D.C. 20549
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York, NY 10279
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chicago, IL 60661-2511</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may also obtain copies of this information by mail from the Public Reference Section of
the SEC, 450 Fifth Street, N.W., Room&nbsp;1024, Washington, D.C. 20549, at prescribed rates. You may
obtain information on the operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC also maintains an Internet world wide web site that contains reports, proxy
statements and other information about issuers, like us, that file electronically with the SEC. The
</DIV>

<P align="center" style="font-size: 10pt">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">address of that site is http://www.sec.gov. You may also inspect reports, proxy statements and
other information about us at the offices of the Nasdaq Stock Market, 9600 Blackwell Road,
Rockville, Maryland 20850.
</DIV>

<DIV align="left">
<A name="105"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus from
documents that we have previously filed with the SEC. This means that we can disclose important
information to you by referring you to another document filed separately with the SEC. These
documents contain important information about us and our financial condition. The information
incorporated by reference is considered to be a part of this prospectus, except for any information
that is superseded by other information that is set forth directly in this document.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus incorporates by reference the following documents with respect to us (file
number: 0-20488):
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our annual report on Form 10-K for the year ended December&nbsp;31, 2005;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our quarterly reports on Form 10-Q for the quarters ended March&nbsp;31, 2006 and
June&nbsp;30, 2006;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our current reports on Form 8-K filed on February&nbsp;28, 2006, May&nbsp;18, 2006 and
May&nbsp;31, 2006; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of our common stock contained in registration statement on Form
S-4 filed with the SEC on June&nbsp;12, 2002, as amended July&nbsp;11, 2002.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incorporate by reference additional documents that we will file with the SEC pursuant to
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this prospectus and the
termination date of the Incentive Plan. These documents include periodic reports, such as annual
reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, as well as
proxy statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent that any statement in this prospectus is inconsistent with any statement that is
incorporated by reference, the statement in this prospectus shall control. The incorporated
statement shall not be deemed, except as modified or superseded, to constitute a part of this
prospectus or the registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may obtain copies of the documents incorporated by reference in this prospectus with
respect to us without charge, excluding any exhibits to those documents unless the exhibit is
specifically incorporated by reference as an exhibit in this prospectus, by requesting them in
writing or by telephone from Brent Turner, Executive Vice President, Finance and Administration,
Psychiatric Solutions, Inc., 840 Crescent Centre Drive, Suite&nbsp;460, Franklin, Tennessee 37067; (615)
312-5700. You may also obtain copies of these documents from the SEC through the SEC&#146;s Internet
world wide web site or at the SEC&#146;s address or phone number described in the section captioned
&#147;AVAILABLE INFORMATION&#148; above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have filed with the SEC a registration statement on Form S-8 under the Securities Act with
respect to Common Stock offered under this prospectus. This prospectus does not contain all of the
information in the registration statement on Form S-8, parts of which we have omitted, as allowed
under the rules and regulations of the SEC. You should refer to the registration statement on Form
S-8 for further information with respect to us and our Common Stock. Statements contained in this
prospectus as to the contents of any contract or other document are not necessarily complete
</DIV>

<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and, in each instance, we refer you to the copy of each contract or document filed as an
exhibit to the registration statement on Form S-8. Copies of the registration statement on Form
S-8, including exhibits, may be inspected without charge at the SEC&#146;s principal office in
Washington, D.C. and copied upon payment of the fees prescribed by the SEC.
</DIV>

<DIV align="left">
<A name="106"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of shares of our Common Stock offered under this prospectus will be passed upon
on our behalf by Waller Lansden Dortch &#038; Davis, LLP, Nashville, Tennessee.
</DIV>
<DIV align="left">
<A name="107"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Psychiatric Solutions, Inc. appearing in
Psychiatric Solutions, Inc.&#146;s Annual Report (Form 10-K) for the year ended December&nbsp;31, 2005, and
Psychiatric Solutions, Inc. management&#146;s assessment of the effectiveness of internal control over
financial reporting as of December&nbsp;31, 2005 included therein, have been audited by Ernst &#038; Young
LLP, independent registered public accounting firm, as set forth in their reports thereon included
therein, and incorporated herein by reference. Such financial statements and management&#146;s
assessment are, and audited financial statements and management&#146;s assessments of the effectiveness
of internal control over financial reporting to be included in subsequently filed documents will
be, incorporated herein in reliance upon the reports of Ernst &#038; Young LLP pertaining to such
financial statements and management&#146;s assessments (to the extent covered by consents filed with the
SEC) given on the authority of such firm as experts in accounting and auditing.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NO DEALER, SALESMAN OR ANY OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE
ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS IN CONNECTION WITH THE OFFERING
HEREIN CONTAINED AND, IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON
AS HAVING BEEN AUTHORIZED BY PSYCHIATRIC SOLUTIONS OR THE SELLING STOCKHOLDERS. THIS PROSPECTUS
DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF ANY OFFER TO BUY, THE SECURITIES OFFERED
HEREBY IN ANY JURISDICTION OR TO ANY PERSON WHOM IT IS UNLAWFUL TO MAKE AN OFFER OR SOLICITATION.
NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES,
CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF PSYCHIATRIC SOLUTIONS SINCE
THE DATE HEREOF OR THAT ANY INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO
ITS DATE.</B>
</DIV>

<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPLANATORY NOTE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This registration statement on Form S-8 relates to the registration of an additional 1,250,000
shares of Common Stock (the &#147;Additional Shares&#148;) issuable pursuant to the Amended and Restated
Psychiatric Solutions, Inc. Equity Incentive Plan, as amended. The Additional Shares are
securities of the same class as those shares registered in the Registrant&#146;s registration statements
on Form S-8, previously filed with the Securities and Exchange Commission (Registration Nos.
33-72664, 333-38419, 333-94983, 333-100635, 333-118529 and 333-128047) filed on December&nbsp;8, 1993,
October&nbsp;21, 1997, January&nbsp;19, 2000, October&nbsp;18, 2002, August&nbsp;25, 2004 and September&nbsp;1, 2005
respectively, which, pursuant to General Instruction E of Form S-8, are incorporated by reference
herein.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The SEC allows us to &#147;incorporate by reference&#148; information into this registration statement
from documents that we have previously filed with the SEC. This means that we can disclose
important information to you by referring you to another document filed separately with the SEC.
The information incorporated by reference is considered to be a part of this registration
statement, except for any information that is superseded by other information that is set forth
directly in this document.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This registration statement incorporates by reference the following documents with respect to
us:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our annual report on Form 10-K for the year ended December&nbsp;31, 2005;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our quarterly reports on Form 10-Q for the quarters ended March&nbsp;31, 2006 and
June&nbsp;30, 2006;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our current reports on Form 8-K filed on February&nbsp;28, 2006, May&nbsp;18, 2006 and
May&nbsp;31, 2006; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of our common stock contained in registration statement on Form
S-4 filed with the SEC on June&nbsp;12, 2002, as amended July&nbsp;11, 2002.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incorporate by reference additional documents that we will file with the SEC pursuant to
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof and prior to the filing
of a post-effective amendment to this registration statement which indicates that all securities
offered hereby have been sold or which deregisters all securities then remaining unsold. These
documents include periodic reports, such as annual reports on Form 10-K, quarterly reports on Form
10-Q and current reports on Form 8-K, as well as proxy statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent that any statement in this registration statement is inconsistent with any
statement that is incorporated by reference, the statement in this registration statement shall
control. The incorporated statement shall not be deemed, except as modified or superseded, to
constitute a part of this the registration statement.
</DIV>

<P align="center" style="font-size: 10pt">II-1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;145 of the Delaware Corporation Law, we are empowered to indemnify our directors
and officers in circumstances therein provided.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Amended and Restated Certificate of Incorporation, as amended, provides that no director
shall be personally liable to us or our stockholders for monetary damages for any breach of
fiduciary duty by such director as a director, except (i)&nbsp;for breach of the director&#146;s duty of
loyalty to us or our stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii)&nbsp;pursuant to Section&nbsp;174 of the Delaware
General Corporation Law, or (iv)&nbsp;for any transaction from which the director derived an improper
personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our Amended and Restated Bylaws, we must indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (other than an action by or in
the right of Psychiatric Solutions) by reason of the fact that he or she is or was a director,
officer, employee or agent of Psychiatric Solutions, or is or was serving at our request as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by him or her in connection with such action, suit
or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be
in or not opposed to our best interests, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his or her conduct was unlawful. The termination of any action,
suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
its equivalent, shall not, of itself, create a presumption that the person did not act in good
faith and in a manner which he or she reasonably believed to be in or not opposed to our best
interests, and, with respect to any criminal action or proceeding, had reasonable cause to believe
that his or her conduct was unlawful.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We must also indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by or in the right of Psychiatric Solutions to
procure a judgment in its favor by reason of the fact that he or she is or was a director, officer,
employee or agent of Psychiatric Solutions, or is or was serving at our request as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other
enterprise against expenses (including attorneys&#146; fees) actually and reasonably incurred by him or
her in connection with the defense or settlement of such action or suit if he or she acted in good
faith and in a manner he or she reasonably believed to be in or not opposed to our best interests,
except that no indemnification shall be made in respect of any claim, issue or matter as to which
such person shall have been adjudged to be liable for negligence or misconduct in the performance
of his or her duty to us unless and only to the extent that the Court of Chancery or the court in
which such action or suit was brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of the case, such person is fairly
and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other
court shall deem proper.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may purchase and maintain insurance, at our expense, to protect us and any of our
directors, officers, employees or agents or the directors, officers, employees or agents of another
corporation, partnership, joint venture, trust or other enterprise, against any such expense,
liability or loss, to the fullest extent permitted by the Delaware General Corporation Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to separate indemnification agreements we have entered into with each of our
directors, we must indemnify and advance expenses to each director to the fullest extent permitted
</DIV>

<P align="center" style="font-size: 10pt">II-2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">by law and as set forth in each agreement and, to the extent applicable, maintain insurance
for the coverage of each director under our policies of directors&#146; and officers&#146; liability
insurance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8. Exhibits.</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March&nbsp;9, 1998 (incorporated by reference to Exhibit&nbsp;3.1 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1998).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August&nbsp;5, 2002 (incorporated by
reference to Exhibit&nbsp;3.2 to the Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended
July&nbsp;31, 2002).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March&nbsp;21, 2003 (incorporated by
reference to Appendix&nbsp;A of the Company&#146;s Definitive Proxy Statement, filed on January&nbsp;22,
2003).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on December&nbsp;15, 2005 (incorporated
by reference to Exhibit&nbsp;3.4 to the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year
ended December&nbsp;31, 2005).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.5</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 to the Company&#146;s Annual
Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1997).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.6</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common Stock Specimen Certificate (incorporated by reference to Exhibit&nbsp;4.2 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2002).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Waller Lansden Dortch &#038; Davis, LLP.</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Ernst &#038; Young LLP.</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Waller Lansden Dortch &#038; Davis, LLP (included in Exhibit&nbsp;5).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Power of Attorney (included on page II-6).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement, filed on
April&nbsp;9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement on April&nbsp;22,
2005, as amended by the Third Amendment to the Psychiatric Solutions, Inc. Equity Incentive
Plan, filed as Appendix&nbsp;B to the Company&#146;s Definitive Proxy Statement on April&nbsp;21, 2006).</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Filed herewith</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt">II-3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9. Undertakings.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The undersigned registrant hereby undertakes:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities
Act of 1933;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than a 20&nbsp;percent change in the maximum aggregate offering price set forth in the
&#147;Calculation of Registration Fee&#148; table in the effective registration statement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any material
change of such information in the registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Provided, however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the Commission by the registrant pursuant to
Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by
reference in the registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide </I>offering thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrant&#146;s annual report pursuant
to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering
thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is therefore unenforceable. In the event that a claim for indemnification against such
liabilities (other
</DIV>

<P align="center" style="font-size: 10pt">II-4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">than the payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will be governed by the
final adjudication of such issue.
</DIV>



<P align="center" style="font-size: 10pt">II-5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Franklin, State of Tennessee, on August&nbsp;4, 2006.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">PSYCHIATRIC SOLUTIONS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Joey A. Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Joey A. Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left"><I>Chairman, Chief Executive Officer and<BR>
President</I>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Joey A. Jacobs and Brent Turner, and each of them, his true and lawful attorney-in-fact,
as agent and with full power of substitution and resubstitution for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments to this Registration Statement,
and to file the same, with all exhibits thereto and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorney-in-fact and agents full power
and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully and to all intents and purposes as they might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any
substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">SIGNATURE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">TITLE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">DATE</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Joey A. Jacobs
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Joey A. Jacobs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chairman, Chief Executive
Officer and President
(Principal Executive
Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ Jack E. Polson
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Jack E. Polson</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chief Accounting Officer
(Principal Financial and
Accounting Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ William F. Carpenter III
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
William F. Carpenter III</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ Mark P. Clein
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Mark P. Clein</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ David M. Dill
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
David M. Dill</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">II-6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">SIGNATURE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">TITLE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">DATE</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ Richard D. Gore
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Richard D. Gore</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ Christopher Grant, Jr.
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Christopher Grant, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ William M. Petrie, M.D.
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
William M. Petrie, M.D.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">/s/ Edward K. Wissing
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Edward K. Wissing</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August 4, 2006</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">II-7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March&nbsp;9, 1998 (incorporated by reference to Exhibit&nbsp;3.1 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1998).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August&nbsp;5, 2002 (incorporated by
reference to Exhibit&nbsp;3.2 to the Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended
July&nbsp;31, 2002).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March&nbsp;21, 2003 (incorporated by
reference to Appendix&nbsp;A of the Company&#146;s Definitive Proxy Statement, filed on January&nbsp;22, 2003).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on December&nbsp;15, 2005 (incorporated
by reference to Exhibit&nbsp;3.4 to the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year
ended December&nbsp;31, 2005).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.5</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 to the Company&#146;s Annual
Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1997).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.6</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common Stock Specimen Certificate (incorporated by reference to Exhibit&nbsp;4.2 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2002).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Waller Lansden Dortch &#038; Davis, LLP.</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Ernst &#038; Young LLP.</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Waller Lansden Dortch &#038; Davis, LLP (included in Exhibit&nbsp;5).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24*</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Power of Attorney (included on page II-6).</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement, filed on
April&nbsp;9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement on April&nbsp;22,
2005, as amended by the Third Amendment to the Psychiatric Solutions, Inc. Equity Incentive
Plan, filed as Appendix&nbsp;B to the Company&#146;s Definitive Proxy Statement on April&nbsp;21, 2006).</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>*Filed herewith</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt">
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g02749sv8.htm", "description": "PSYCHIATRIC SOLUTIONS, INC.", "secsgml_size_bytes": 80196}]
{"company-data": {"conformed-name": "PSYCHIATRIC SOLUTIONS INC", "cik": "0000829608", "assigned-sic": "8093", "irs-number": "232491707", "state-of-incorporation": "DE", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-136339", "film-number": "061006621"}, "business-address": {"street1": "113 SEABOARD LANE", "street2": "SUITE C-100", "city": "FRANKLIN", "state": "TN", "zip": "37067", "phone": "615-312-5700"}, "mail-address": {"street1": "113 SEABOARD LANE", "street2": "SUITE C-100", "city": "FRANKLIN", "state": "TN", "zip": "37067"}, "former-company": [{"former-conformed-name": "PMR CORP", "date-changed": "19920703"}, {"former-conformed-name": "ZARON CAPITAL INC", "date-changed": "19891116"}]}
PSYCHIATRIC SOLUTIONS, INC.
Table of Contents
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 4, 2006
REGISTRATION NO. 333-________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
PSYCHIATRIC SOLUTIONS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
23-2491707
(State or Other Jurisdiction of
(I.R.S. Employer
Incorporation or Organization)
Identification No.)
840 Crescent Centre Drive, Suite 460
Franklin, Tennessee
37067
(Address of Principal Executive Offices)
(Zip Code)
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
(Full title of the plan)
Christopher L. Howard, Esq.
Executive Vice President, General Counsel and Secretary
Psychiatric Solutions, Inc.
840 Crescent Centre Drive, Suite 460
Franklin, Tennessee 37067
(Name and Address of Agent for Service)
(615) 312-5700
(Telephone number, including area code, of agent for service)
Copies of all communications to:
James H. Nixon III, Esq.
Waller Lansden Dortch & Davis, LLP
511 Union Street, Suite 2700
Nashville, Tennessee 37219-1760
(615) 244-6380
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Amount Of
Title Of Each Class Of
Amount To Be
Maximum Offering
Maximum Aggregate
Registration
Securities To Be Registered
Registered
Price Per Unit
Offering Price
Fee (3)
Common Stock of
Psychiatric
Solutions, Inc.,
par value $0.01 per
share
1,250,000 (1)
$
30.98
(2)
$
38,725,000
$
4,144
(1)
Represents shares of common stock, par value $.01 per share ("Common Stock"), of
Psychiatric Solutions, Inc. ("Psychiatric Solutions") reserved for issuance pursuant to future
grants of stock options under the Amended and Restated Psychiatric Solutions, Inc. Equity
Incentive Plan, as amended (the "Equity Incentive Plan").
(2)
Estimated pursuant to Rule 457(c) solely for purposes of calculating the amount of the
registration fee, based upon the average of the high and low prices of Common Stock of
Psychiatric Solutions, as reported on the Nasdaq Global Select Market on July 31, 2006.
(3)
The Equity Incentive Plan authorizes the issuance of a maximum of 11,116,666 shares of Common
Stock, of which 4,000,000 shares have been registered pursuant to a previously filed
registration statement on Form S-8 (No. 333-128047), 957,132 shares have been registered pursuant to a previously filed registration
statement on Form S-8 (No. 333-38419), 666,666 shares have been registered on a previously
filed registration statement on Form S-8 (No. 333-94983), 3,246,112 shares have been
registered pursuant to a previously filed registration statement on Form S-8 (No. 333-118529)
and 333,332 shares have been registered on a previously filed registration statement on Form
S-8 (No. 33-72664). In connection with the amendment and restatement of the Equity Incentive
Plan on May 6, 2003, the Psychiatric Solutions, Inc. 1997 Incentive and Non-Qualified Stock
Option Plan for Key Personnel (the "Psychiatric Plan") was merged into the Equity Incentive
Plan. The Psychiatric Plan authorized the issuance of a maximum of 331,712 shares of Common
Stock, all of which shares have been registered pursuant to a previously filed registration
statement on Form S-8 (No. 333-100635). An additional 1,250,000 shares of Common Stock are
being registered herewith and, in accordance with General Instruction E of Form S-8, the fee
is being paid only with respect to these shares. All share numbers, purchase prices per share
and exercise prices set forth in this registration statement have been adjusted to reflect (a)
the exchange ratio in the merger between Psychiatric Solutions and PMR Corporation on August
5, 2002, (b) a 1-for-3 reverse stock split effected on August 5, 2002 and (c) a 2-for-1 stock
split effected in the form of a 100% stock dividend on January 9, 2006.
Table of Contents
Reoffer Prospectus
1,250,000 Shares
Psychiatric Solutions, Inc.
Common Stock
This prospectus has been prepared for use by certain affiliates and employees (the "Selling
Stockholders") of Psychiatric Solutions, Inc. ("Psychiatric Solutions") who may offer and sell up
to an aggregate of 1,250,000 shares of common stock, par value $.01 per share ("Common Stock"),
that the Selling Stockholders acquire pursuant to the Amended and Restated Psychiatric Solutions,
Inc. Equity Incentive Plan, as amended (the "Incentive Plan"), or upon the exercise, subsequent to
the date of this reoffer prospectus, of stock options granted pursuant to the Incentive Plan.
This prospectus may only be used in conjunction with a supplement, if required under the
Securities Act of 1933, as amended (the "Securities Act"), that contains the names of the Selling
Stockholders and the amount of shares of Common Stock to be reoffered by them.
We will not receive any of the proceeds from the sale of the shares by the Selling
Stockholders. We will bear all expenses (other than underwriting discounts and selling
commissions, fees and expenses of counsel and other advisors to the Selling Stockholders, transfer
taxes and related charges) in connection with the registration of the shares being offered by the
Selling Stockholders.
Our
Common Stock is listed on the Nasdaq Global Select Market under the symbol "PSYS." We are
incorporated under the laws of the State of Delaware. Our principal executive offices are located
at 840 Crescent Centre Drive, Suite 460, Franklin, Tennessee 37067 and our telephone number is
(615) 312-5700.
Investing in our Common Stock involves certain risks. Please carefully consider the "Risk
Factors" in our Annual Report on
Form 10-K
filed on March 2, 2006, and incorporated by reference
into this prospectus.
Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission
has approved or disapproved of these securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is August 4, 2006.
Table of Contents
TABLE OF CONTENTS
Heading
Page
Use of Proceeds
1
Selling Stockholders
1
Plan of Distribution
1
Available Information
1
Incorporation of Certain Information By Reference
2
Legal Matters
3
Experts
3
Table of Contents
USE OF PROCEEDS
We will not receive any proceeds from the sale of shares of Common Stock by the Selling
Stockholders.
SELLING STOCKHOLDERS
The shares of Common Stock issued pursuant to the Incentive Plan or upon the exercise,
subsequent to the date of this reoffer prospectus, of stock options granted pursuant to the
Incentive Plan have been registered under the Securities Act by a registration statement on Form
S-8. This prospectus may be used in connection with any resales of Common Stock acquired pursuant
to the Incentive Plan after the date of the registration statement on Form S-8 by persons who may
be considered our "affiliates" within the meaning of the Securities Act.
At the date of this prospectus, we do not know the names of persons who intend to resell
shares of Common Stock acquired pursuant to the Incentive Plan. The Selling Stockholders will be
either employees, consultants or advisors of Psychiatric Solutions or its subsidiaries who have
been or may be granted options to purchase Common Stock or restricted shares of Common Stock under
the Incentive Plan. We will supplement this prospectus with the names of the Selling Stockholders
and the amount of shares of Common Stock to be reoffered by them as that information becomes known
and is required by the Securities Act.
PLAN OF DISTRIBUTION
The shares may be offered by the Selling Stockholders from time to time in transactions
through the Nasdaq Global Select Market, in negotiated transactions, through the writing of options on
the shares or a combination of these methods of sale, at prices related to prevailing market prices
or at negotiated prices. The Selling Stockholders may effect these transactions by selling the
shares to or through broker-dealers and these broker-dealers may receive compensation in the form
of discounts, concessions or commissions from the Selling Stockholders and/or the purchaser of the
shares for which such broker-dealers may act as agent or to whom they sell as principal, or both.
This compensation as to a particular broker-dealer may be in excess of customary commissions.
There is no assurance that any of the Selling Stockholders will sell any or all of the shares
of Common Stock offered under this prospectus.
AVAILABLE INFORMATION
We are subject to the informational requirements of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and, in accordance therewith, we file reports, proxy statements and
other information with the SEC under the Exchange Act. You may read and copy this information on
our website at www.psysolutions.com and at the following locations of the SEC:
Public Reference Room
New York Regional Office
Chicago Regional Office
450 Fifth Street, N.W.
Woolworth Center
Citicorp Center, Suite 1400
Room 1024
233 Broadway
500 West Madison Street
Washington, D.C. 20549
New York, NY 10279
Chicago, IL 60661-2511
You may also obtain copies of this information by mail from the Public Reference Section of
the SEC, 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549, at prescribed rates. You may
obtain information on the operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC also maintains an Internet world wide web site that contains reports, proxy
statements and other information about issuers, like us, that file electronically with the SEC. The
1
Table of Contents
address of that site is http://www.sec.gov. You may also inspect reports, proxy statements and
other information about us at the offices of the Nasdaq Stock Market, 9600 Blackwell Road,
Rockville, Maryland 20850.
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to "incorporate by reference" information into this prospectus from
documents that we have previously filed with the SEC. This means that we can disclose important
information to you by referring you to another document filed separately with the SEC. These
documents contain important information about us and our financial condition. The information
incorporated by reference is considered to be a part of this prospectus, except for any information
that is superseded by other information that is set forth directly in this document.
This prospectus incorporates by reference the following documents with respect to us (file
number: 0-20488):
1.
Our annual report on Form 10-K for the year ended December 31, 2005;
2.
Our quarterly reports on Form 10-Q for the quarters ended March 31, 2006 and
June 30, 2006;
3.
Our current reports on Form 8-K filed on February 28, 2006, May 18, 2006 and
May 31, 2006; and
4.
The description of our common stock contained in registration statement on Form
S-4 filed with the SEC on June 12, 2002, as amended July 11, 2002.
We incorporate by reference additional documents that we will file with the SEC pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this prospectus and the
termination date of the Incentive Plan. These documents include periodic reports, such as annual
reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, as well as
proxy statements.
To the extent that any statement in this prospectus is inconsistent with any statement that is
incorporated by reference, the statement in this prospectus shall control. The incorporated
statement shall not be deemed, except as modified or superseded, to constitute a part of this
prospectus or the registration statement.
You may obtain copies of the documents incorporated by reference in this prospectus with
respect to us without charge, excluding any exhibits to those documents unless the exhibit is
specifically incorporated by reference as an exhibit in this prospectus, by requesting them in
writing or by telephone from Brent Turner, Executive Vice President, Finance and Administration,
Psychiatric Solutions, Inc., 840 Crescent Centre Drive, Suite 460, Franklin, Tennessee 37067; (615)
312-5700. You may also obtain copies of these documents from the SEC through the SEC's Internet
world wide web site or at the SEC's address or phone number described in the section captioned
"AVAILABLE INFORMATION" above.
We have filed with the SEC a registration statement on Form S-8 under the Securities Act with
respect to Common Stock offered under this prospectus. This prospectus does not contain all of the
information in the registration statement on Form S-8, parts of which we have omitted, as allowed
under the rules and regulations of the SEC. You should refer to the registration statement on Form
S-8 for further information with respect to us and our Common Stock. Statements contained in this
prospectus as to the contents of any contract or other document are not necessarily complete
2
Table of Contents
and, in each instance, we refer you to the copy of each contract or document filed as an
exhibit to the registration statement on Form S-8. Copies of the registration statement on Form
S-8, including exhibits, may be inspected without charge at the SEC's principal office in
Washington, D.C. and copied upon payment of the fees prescribed by the SEC.
LEGAL MATTERS
The validity of shares of our Common Stock offered under this prospectus will be passed upon
on our behalf by Waller Lansden Dortch & Davis, LLP, Nashville, Tennessee.
EXPERTS
The consolidated financial statements of Psychiatric Solutions, Inc. appearing in
Psychiatric Solutions, Inc.'s Annual Report (Form 10-K) for the year ended December 31, 2005, and
Psychiatric Solutions, Inc. management's assessment of the effectiveness of internal control over
financial reporting as of December 31, 2005 included therein, have been audited by Ernst & Young
LLP, independent registered public accounting firm, as set forth in their reports thereon included
therein, and incorporated herein by reference. Such financial statements and management's
assessment are, and audited financial statements and management's assessments of the effectiveness
of internal control over financial reporting to be included in subsequently filed documents will
be, incorporated herein in reliance upon the reports of Ernst & Young LLP pertaining to such
financial statements and management's assessments (to the extent covered by consents filed with the
SEC) given on the authority of such firm as experts in accounting and auditing.
NO DEALER, SALESMAN OR ANY OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE
ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS IN CONNECTION WITH THE OFFERING
HEREIN CONTAINED AND, IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON
AS HAVING BEEN AUTHORIZED BY PSYCHIATRIC SOLUTIONS OR THE SELLING STOCKHOLDERS. THIS PROSPECTUS
DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF ANY OFFER TO BUY, THE SECURITIES OFFERED
HEREBY IN ANY JURISDICTION OR TO ANY PERSON WHOM IT IS UNLAWFUL TO MAKE AN OFFER OR SOLICITATION.
NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES,
CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF PSYCHIATRIC SOLUTIONS SINCE
THE DATE HEREOF OR THAT ANY INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO
ITS DATE.
3
Table of Contents
EXPLANATORY NOTE
This registration statement on Form S-8 relates to the registration of an additional 1,250,000
shares of Common Stock (the "Additional Shares") issuable pursuant to the Amended and Restated
Psychiatric Solutions, Inc. Equity Incentive Plan, as amended. The Additional Shares are
securities of the same class as those shares registered in the Registrant's registration statements
on Form S-8, previously filed with the Securities and Exchange Commission (Registration Nos.
33-72664, 333-38419, 333-94983, 333-100635, 333-118529 and 333-128047) filed on December 8, 1993,
October 21, 1997, January 19, 2000, October 18, 2002, August 25, 2004 and September 1, 2005
respectively, which, pursuant to General Instruction E of Form S-8, are incorporated by reference
herein.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The SEC allows us to "incorporate by reference" information into this registration statement
from documents that we have previously filed with the SEC. This means that we can disclose
important information to you by referring you to another document filed separately with the SEC.
The information incorporated by reference is considered to be a part of this registration
statement, except for any information that is superseded by other information that is set forth
directly in this document.
This registration statement incorporates by reference the following documents with respect to
us:
1.
Our annual report on Form 10-K for the year ended December 31, 2005;
2.
Our quarterly reports on Form 10-Q for the quarters ended March 31, 2006 and
June 30, 2006;
3.
Our current reports on Form 8-K filed on February 28, 2006, May 18, 2006 and
May 31, 2006; and
4.
The description of our common stock contained in registration statement on Form
S-4 filed with the SEC on June 12, 2002, as amended July 11, 2002.
We incorporate by reference additional documents that we will file with the SEC pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof and prior to the filing
of a post-effective amendment to this registration statement which indicates that all securities
offered hereby have been sold or which deregisters all securities then remaining unsold. These
documents include periodic reports, such as annual reports on Form 10-K, quarterly reports on Form
10-Q and current reports on Form 8-K, as well as proxy statements.
To the extent that any statement in this registration statement is inconsistent with any
statement that is incorporated by reference, the statement in this registration statement shall
control. The incorporated statement shall not be deemed, except as modified or superseded, to
constitute a part of this the registration statement.
II-1
Table of Contents
Item 6. Indemnification of Directors and Officers.
Under Section 145 of the Delaware Corporation Law, we are empowered to indemnify our directors
and officers in circumstances therein provided.
Our Amended and Restated Certificate of Incorporation, as amended, provides that no director
shall be personally liable to us or our stockholders for monetary damages for any breach of
fiduciary duty by such director as a director, except (i) for breach of the director's duty of
loyalty to us or our stockholders, (ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the Delaware
General Corporation Law, or (iv) for any transaction from which the director derived an improper
personal benefit.
Under our Amended and Restated Bylaws, we must indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (other than an action by or in
the right of Psychiatric Solutions) by reason of the fact that he or she is or was a director,
officer, employee or agent of Psychiatric Solutions, or is or was serving at our request as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by him or her in connection with such action, suit
or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be
in or not opposed to our best interests, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his or her conduct was unlawful. The termination of any action,
suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
its equivalent, shall not, of itself, create a presumption that the person did not act in good
faith and in a manner which he or she reasonably believed to be in or not opposed to our best
interests, and, with respect to any criminal action or proceeding, had reasonable cause to believe
that his or her conduct was unlawful.
We must also indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by or in the right of Psychiatric Solutions to
procure a judgment in its favor by reason of the fact that he or she is or was a director, officer,
employee or agent of Psychiatric Solutions, or is or was serving at our request as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other
enterprise against expenses (including attorneys' fees) actually and reasonably incurred by him or
her in connection with the defense or settlement of such action or suit if he or she acted in good
faith and in a manner he or she reasonably believed to be in or not opposed to our best interests,
except that no indemnification shall be made in respect of any claim, issue or matter as to which
such person shall have been adjudged to be liable for negligence or misconduct in the performance
of his or her duty to us unless and only to the extent that the Court of Chancery or the court in
which such action or suit was brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of the case, such person is fairly
and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other
court shall deem proper.
We may purchase and maintain insurance, at our expense, to protect us and any of our
directors, officers, employees or agents or the directors, officers, employees or agents of another
corporation, partnership, joint venture, trust or other enterprise, against any such expense,
liability or loss, to the fullest extent permitted by the Delaware General Corporation Law.
Pursuant to separate indemnification agreements we have entered into with each of our
directors, we must indemnify and advance expenses to each director to the fullest extent permitted
II-2
Table of Contents
by law and as set forth in each agreement and, to the extent applicable, maintain insurance
for the coverage of each director under our policies of directors' and officers' liability
insurance.
Item 8. Exhibits.
Exhibit
Number
Description of Exhibits
4.1
Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company's
Annual Report on Form 10-K for the fiscal year ended April 30, 1998).
4.2
Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by
reference to Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended
July 31, 2002).
4.3
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by
reference to Appendix A of the Company's Definitive Proxy Statement, filed on January 22,
2003).
4.4
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on December 15, 2005 (incorporated
by reference to Exhibit 3.4 to the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 2005).
4.5
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Annual
Report on Form 10-K for the fiscal year ended April 30, 1997).
4.6
Common Stock Specimen Certificate (incorporated by reference to Exhibit 4.2 to the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
5*
Opinion of Waller Lansden Dortch & Davis, LLP.
23.1*
Consent of Ernst & Young LLP.
23.2*
Consent of Waller Lansden Dortch & Davis, LLP (included in Exhibit 5).
24*
Power of Attorney (included on page II-6).
99
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix A to the Company's Definitive Proxy Statement, filed on
April 9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix A to the Company's Definitive Proxy Statement on April 22,
2005, as amended by the Third Amendment to the Psychiatric Solutions, Inc. Equity Incentive
Plan, filed as Appendix B to the Company's Definitive Proxy Statement on April 21, 2006).
*
Filed herewith
II-3
Table of Contents
Item 9. Undertakings.
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities
Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than a 20 percent change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective registration statement;
(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any material
change of such information in the registration statement.
Provided, however
, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the Commission by the registrant pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by
reference in the registration statement.
(2) That, for the purpose of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial
bona fide
offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
(b) The undersigned registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant
to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide
offering
thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is therefore unenforceable. In the event that a claim for indemnification against such
liabilities (other
II-4
Table of Contents
than the payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will be governed by the
final adjudication of such issue.
II-5
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Franklin, State of Tennessee, on August 4, 2006.
PSYCHIATRIC SOLUTIONS, INC.
By:
/s/ Joey A. Jacobs
Joey A. Jacobs
Chairman, Chief Executive Officer and
President
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Joey A. Jacobs and Brent Turner, and each of them, his true and lawful attorney-in-fact,
as agent and with full power of substitution and resubstitution for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments to this Registration Statement,
and to file the same, with all exhibits thereto and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorney-in-fact and agents full power
and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully and to all intents and purposes as they might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any
substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE
TITLE
DATE
/s/ Joey A. Jacobs
Joey A. Jacobs
Chairman, Chief Executive
Officer and President
(Principal Executive
Officer)
August 4, 2006
/s/ Jack E. Polson
Jack E. Polson
Chief Accounting Officer
(Principal Financial and
Accounting Officer)
August 4, 2006
/s/ William F. Carpenter III
William F. Carpenter III
Director
August 4, 2006
/s/ Mark P. Clein
Mark P. Clein
Director
August 4, 2006
/s/ David M. Dill
David M. Dill
Director
August 4, 2006
II-6
Table of Contents
SIGNATURE
TITLE
DATE
/s/ Richard D. Gore
Richard D. Gore
Director
August 4, 2006
/s/ Christopher Grant, Jr.
Christopher Grant, Jr.
Director
August 4, 2006
/s/ William M. Petrie, M.D.
William M. Petrie, M.D.
Director
August 4, 2006
/s/ Edward K. Wissing
Edward K. Wissing
Director
August 4, 2006
II-7
Table of Contents
INDEX TO EXHIBITS
Exhibit
Number
Description of Exhibits
4.1
Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company's
Annual Report on Form 10-K for the fiscal year ended April 30, 1998).
4.2
Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by
reference to Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended
July 31, 2002).
4.3
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by
reference to Appendix A of the Company's Definitive Proxy Statement, filed on January 22, 2003).
4.4
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on December 15, 2005 (incorporated
by reference to Exhibit 3.4 to the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 2005).
4.5
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Annual
Report on Form 10-K for the fiscal year ended April 30, 1997).
4.6
Common Stock Specimen Certificate (incorporated by reference to Exhibit 4.2 to the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
5*
Opinion of Waller Lansden Dortch & Davis, LLP.
23.1*
Consent of Ernst & Young LLP.
23.2*
Consent of Waller Lansden Dortch & Davis, LLP (included in Exhibit 5).
24*
Power of Attorney (included on page II-6).
99
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix A to the Company's Definitive Proxy Statement, filed on
April 9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix A to the Company's Definitive Proxy Statement on April 22,
2005, as amended by the Third Amendment to the Psychiatric Solutions, Inc. Equity Incentive
Plan, filed as Appendix B to the Company's Definitive Proxy Statement on April 21, 2006).
*Filed herewith